Month: February 2024

LONDON, Feb. 29, 2024 (GLOBE NEWSWIRE) —Highlights:COMP360 phase 3 pivotal program ongoing; COMP005 trial top-line data now expected in fourth quarter 2024, COMP006 remains on track for top-line data in mid-2025 Teri Loxam to assume Chief Financial Officer role on March 1, 2024 Cash position of $220.2 million at December 31, 2023, additional $31.4 million net cash raised to date in first quarter 2024 Conference call February 29 at 8:00 am ET (1:00 pm UK)Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the fourth quarter 2023 and provided an update on recent progress across its business. Kabir Nath, Chief Executive Officer, said, “We continue to progress our two phase...

TORONTO, Feb. 29, 2024 (GLOBE NEWSWIRE) — Hemlo Explorers Inc. (the “Company”) (TSXV: HMLO) is pleased to announce that it has received the final tranche of the $200,000 that it was awarded under the Ontario Junior Exploration Program (“OJEP”) from the Ontario Government. This amount covered up to 50% of eligible exploration costs, to a maximum of $200,000 in respect of expenditures incurred by the Company during the period from April 1, 2023 to February 15, 2024.   “We would like to thank the Ontario Government for this funding under the OJEP program. It is a vital part of financing our projects,” commented Brian Howlett, President and CEO of the Company. Through OJEP, the Ontario Government is investing in early exploration to create meaningful opportunities for junior companies to find the mines of the future. Incentivizing...

Record full-year 2023 preliminary unaudited revenue of EUR 60.4 million ($65.4 million USD), an increase of 9.6% over full-year 2022, driven by 31.7% HIFU growth Record Q4 2023 preliminary unaudited revenue of EUR 19.6 million ($21.3 million USD), an increase of 24.8% over for Q4 2022, driven by 38.8% HIFU growth Strong Q4 2023 U.S. Focal One® HIFU procedure growth of 136% year-over-yearLYON, France, February 29, 2024 – EDAP TMS SA (Nasdaq: EDAP), a global leader in robotic energy-based therapies, today announced preliminary unaudited fourth quarter and full-year 2023 revenues. “Our fourth quarter and full-year 2023 revenues each hit record levels driven by increased demand for Focal One Robotic HIFU and solid execution from our capital sales and regional clinical teams,” said Ryan Rhodes, Chief Executive Officer of EDAP TMS....

LIVONIA, Mich., Feb. 29, 2024 (GLOBE NEWSWIRE) — Alta Equipment Group Inc. (NYSE: ALTG) (“Alta” or the Company”), a leading provider of premium material handling, construction and environmental processing equipment and related services, today announced that it will report its financial results for the fourth quarter and year ended December 31, 2023, after the U.S. markets close on Thursday, March 14, 2024. In conjunction with this announcement, Alta management will host a conference call and webcast that afternoon at 5:00 p.m. Eastern Time to discuss and answer questions about the Company’s financial results. Prior to the conference call and webcast, Alta will issue a press release and supplementary presentation slides reporting these results on the Investors portion of the Company’s website, https://investors.altaequipment.com. Conference...

CHICAGO and VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) — RISE Dispensaries, a rapidly growing cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), today announced the opening of its 15th retail location in Florida and 92nd nationwide, RISE Dispensary Dunnellon. Located at 11192 N. Williams St., RISE Dispensary Dunnellon will open on Friday, March 1, with special discounts and complimentary merchandise for the store’s first customers. The new store will offer medical cannabis patients a range of high-quality THC and CBD products, including RYTHM premium flower and full spectrum vapes, Dogwalkers pre-rolls, Good Green flower, and &Shine flower, pre-rolls, vapes and chews. “We are thrilled to be the first dispensary to open in the City of Dunnellon,...

— Company Delivers Total Revenues of $75 Million in the Fourth Quarter and $306 Million for the Full-Year 2023 —— Reaffirms Year-End 2023 Cash Position of $321 Million and Full-Year Positive Cash Flow of $10 Million — — Company Reports Fourth Quarter 2023 Total Operating Expense of $50 Million —— Initiated Shareholder Approval Process to Execute a Share Repurchase Program of up to $50 Million by the End of the Second Quarter 2024 —— Company to Host Conference Call Today at 8:00 a.m. EDT — DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), today announced financial results for the quarter and year ended December 31, 2023 and provided an update on the Company’s operations. “Our team is delivering operational momentum...

Figure 1Lithium Ionic’s Itinga Group of Properties Showing the Vale and Borges ClaimsTORONTO, Feb. 29, 2024 (GLOBE NEWSWIRE) — Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (“Lithium Ionic” or the “Company”) reports that is has amended the purchase agreements related to the acquisition of certain of its Itinga properties, in Minas Gerais, Brazil. The amendments are as follows: Vale Claims:On January 20, 2023, Lithium Ionic’s 100%-owned Brazilian subsidiary, MGLIT Empreendimentos Ltda. (“MGLIT”), entered into a purchase agreement with Exotic Mineração Ltda. pursuant to which MGLIT had the option to acquire up to a 100% equity interest in Vale do Lítio Mineração Ltda. (respectively, the “Vale do Lítio Agreement” and “Vale do Lítio”). Vale do Lítio has a 100% beneficial ownership interest in three lithium mining...

WATERTOWN, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) —  EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, March 7, 2024 to report its fourth quarter and full-year 2023 financial results and highlight recent corporate developments. To access the live conference call, please register using the audio conference link: https://register.vevent.com/register/BI91be5d0e320646e887cf4047c70fe73c. A live audio webcast of the event can be accessed via the Investors section of the Company website at www.eyepointpharma.com. A webcast replay will also be available on the corporate website at the conclusion of the call. About EyePoint...